The effect of sepsis and its inflammatory response on mechanical clot characteristics: a prospective observational study-Reference-Cited by-同舟云学术

The effect of sepsis and its inflammatory response on mechanical clot characteristics: a prospective observational study

Published:2016-09-03 Issue:12 Volume:42 Page:1990-1998
ISSN:0342-4642
Container-title:Intensive Care Medicine
language:en
Short-container-title:Intensive Care Med

Author:

Davies Gareth R.,Pillai Suresh,Lawrence Matthew,Mills Gavin M.,Aubrey Robert,D’Silva Lindsay,Battle Ceri,Williams Rhodri,Brown Rowan,Thomas Dafydd,Morris Keith,Evans Phillip Adrian^ORCID

Funder

National Institute for Social Care and Health Research

Publisher

Springer Science and Business Media LLC

Subject

Critical Care and Intensive Care Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00134-016-4496-z.pdf

Reference32 articles.

1. Schouten M, Wiersinga WJ, Levi M, Van Der Poll T (2006) Inflammation, endothelium, and coagulation in sepsis. J Leukoc Biol 79:536–545

2. Dhainaut J-F, Shorr AF, Macias WL, Kollef MJ, Levi M, Reinhart K, Nelson DR (2005) Dynamic evolution of coagulopathy in the first day of severe sepsis: relationship with mortality and organ failure. Crit Care Med 33:341–348

3. Ranieri VM, Thompson BT, Barie PS, Dhainaut J-F, Douglas IS, Finfer S, Gårdlund B, Marshall JC, Rhodes A, Artigas A, Payen D, Tenhunen J, Al-Khalidi HR, Thompson V, Janes J, Macias WL, Vangerow B, Williams MD (2012) Drotrecogin alfa (activated) in adults with septic shock. N Engl J Med 366:2055–2064

4. Rimmer E, Kumar A, Doucette S, Marshall J, Dial S, Gurka D, Dellinger RP, Sharma S, Penner C, Kramer A, Wood K, Ronald J, Kumar A, Turgeon AF, Houston DS, Zarychanski R (2012) Activated protein C and septic shock: a propensity-matched cohort study. Crit Care Med 40:2974–2981

5. Abraham E, Opal S, Demeyer I, Lo A, Svoboda P, Laterre F, Simon S, Light B, Peckelsen C, De Deyne C, Percell SR, Shu V, Poole L, Creasey AA (2003) Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial. JAMA 290:238–247

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The efficacy of low molecular weight heparin is reduced in Covid-19;Clinical Hemorheology and Microcirculation;2022-11-19

2. A comparative study into the effects of venous and arterial blood on clot microstructure in critically unwell patients. Assessment of the diagnostic potential of a biomarker of haemostasis;Journal of the Intensive Care Society;2021-12-07

3. Fibrin Network Formation and Lysis in Septic Shock Patients;International Journal of Molecular Sciences;2021-09-02

4. Fibrinolytic Alterations in Sepsis: Biomarkers and Future Treatment Targets;Seminars in Thrombosis and Hemostasis;2021-04-20

5. The effect of diabetic ketoacidosis (DKA) and its treatment on clot microstructure: Are they thrombogenic?;Clinical Hemorheology and Microcirculation;2021-03-19